Literature DB >> 9346290

Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13).

V Knäuper1, B Smith, C López-Otin, G Murphy.   

Abstract

Human progelatinase B was activated by collagenase-3 in a time-dependent fashion. Activation proceeded through an intermediate form of Mr 86,000 to the final active form of Mr 82,000. N-terminal amino acid sequence determination demonstrated that the Glu40-Met41 peptide bond was initially hydrolysed followed by cleavage of the Arg87-Phe88 peptide bond releasing the rest of the propeptide domain which was accompanied by the achievement of maximal enzymatic activity as revealed using a quenched fluorescent substrate. Kinetic analysis of activation revealed that the rates were dependent on the concentration of the proenzyme as well as active collagenase-3. Active gelatinase B did not contribute to the activation rate of the proenzyme initiated by collagenase-3 and our results indicate that progelatinase B activation proceeds via bimolecular cleavage with collagenase-3 involving sequential cleavage of the propeptide in two steps. The activation rates were not dependent on C-terminal domain interactions between progelatinase B and collagenase-3, as assessed using wild-type and C-terminal deletion mutants of both enzymes. Since elevated levels of both gelatinase B and collagenase-3 have been observed in arthritis and breast cancer pathology these enzymes may well form a proteolytic cascade in these diseases which allows rapid turnover of the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9346290     DOI: 10.1111/j.1432-1033.1997.00369.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  45 in total

1.  Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer.

Authors:  Diaa Al-Raawi; Helal Abu-El-Zahab; Mohamed El-Shinawi; Mona Mostafa Mohamed
Journal:  Int J Clin Exp Med       Date:  2011-10-11

Review 2.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

3.  Classically activated macrophages use stable microtubules for matrix metalloproteinase-9 (MMP-9) secretion.

Authors:  Raed Hanania; He Song Sun; Kewei Xu; Sofia Pustylnik; Sujeeve Jeganathan; Rene E Harrison
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

4.  Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue.

Authors:  Zhong Dong; R Daniel Bonfil; Sreenivasa Chinni; Xiyun Deng; J Carlos Trindade Filho; Margarida Bernardo; Ulka Vaishampayan; Mingxin Che; Bonnie F Sloane; Shijie Sheng; Rafael Fridman; Michael L Cher
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

Review 5.  Matrix metalloproteases: underutilized targets for drug delivery.

Authors:  Deepali G Vartak; Richard A Gemeinhart
Journal:  J Drug Target       Date:  2007-01       Impact factor: 5.121

6.  Collagenase expression and activity in the stromal cells from giant cell tumour of bone.

Authors:  Robert W Cowan; Isabella W Y Mak; Nigel Colterjohn; Gurmit Singh; Michelle Ghert
Journal:  Bone       Date:  2009-02-12       Impact factor: 4.398

7.  Mutations in MMP9 and MMP13 determine the mode of inheritance and the clinical spectrum of metaphyseal anadysplasia.

Authors:  Ekkehart Lausch; Romy Keppler; Katja Hilbert; Valerie Cormier-Daire; Sarah Nikkel; Gen Nishimura; Sheila Unger; Jürgen Spranger; Andrea Superti-Furga; Bernhard Zabel
Journal:  Am J Hum Genet       Date:  2009-07-16       Impact factor: 11.025

8.  Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid.

Authors:  Lan Lin; Eric Bankaitis; Lisa Heimbach; Ning Li; Magnus Abrink; Gunnar Pejler; Lijia An; Luis A Diaz; Zena Werb; Zhi Liu
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

9.  Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients.

Authors:  Christian G Sauer; Alexandra Kappeler; Monika Späth; Jens J Kaden; Maurice S Michel; Doris Mayer; Uwe Bleyl; Rainer Grobholz
Journal:  Virchows Arch       Date:  2004-04-16       Impact factor: 4.064

10.  Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development.

Authors:  C B Little; A Barai; D Burkhardt; S M Smith; A J Fosang; Z Werb; M Shah; E W Thompson
Journal:  Arthritis Rheum       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.